Oral Deflazacort, Drug Exposure

Simple item page
dc.contributor.advisorMitsnefes, Mark
dc.contributor.authorDickinson, Kimberly
dc.contributor.otherChildren's Hospital of Philadelphia
dc.date.accessioned2024-06-10T19:03:22Z
dc.date.available2024-06-10T19:03:22Z
dc.date.created2022-02-01
dc.descriptionThis concept set contains oral deflazacort. There are no combinations. This concept set was generated by taking all descendants of oral deflazacort from the SCDG level. The codeset was reviewed by the PRESERVE BPZ workgroup led by Mark Mitsnefes. This codeset was created as part of the inclusion/exclusion criteria for the cohort of patients for the development and evaluation of EHR-based pediatric blood pressure Z-scores. One of the exclusion criteria was exposure to specific steroids (including oral deflazacort) at any time. This concept set is limited to medications in the RxNorm and RxNorm Extension vocabularies.
dc.description.abstractConcept set intended to identify patients with an exposure to oral Deflazacort.
dc.identifier.urihttps://pedsnet.org/metadata/handle/20.500.14642/527
dc.provenancePreserving Kidney Function in Children with Chronic Kidney Disease (PRESERVE)
dc.publisherPEDSnet
dc.relation.urihttps://github.com/PRESERVE-Coordinating-Center/PRESERVE_Variables/blob/dfe52bdc48cfcfd6b358d4a424b5d39749554025/codesets/drug/rx_deflazacort.csv
dc.rightsa CC-BY Attribution 4.0 License.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectConcept Set Development::Content Data Model::PEDSnet Data Model
dc.subjectConcept Set Development::Content Data Model::PCORnet Data Model
dc.subjectConcept Set Development::Concept Set Development Strategy::Variable Characterization::Independent Variable
dc.subjectConcept Set Development::Concept Set Development Strategy::Cohort Characterization::Exclusion Criteria
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Brand Pack Name
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug Form
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug Form
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug Component
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug Component
dc.subjectConcept Set Development::Concept Set Evaluation::Clinician Reviewed
dc.subject.meshDeflazacort
dc.subject.meshCorticosteroid
dc.subject.meshSteroid
dc.subject.meshHormone
dc.subject.meshReceptor Agonist
dc.subject.otherRxNorm
dc.subject.otherRxNorm Extension
dc.titleOral Deflazacort, Drug Exposure
dspace.entity.typeConceptSet
local.quality.statusResearch-Ready
local.subject.DataModelPEDSnet Data Model
local.subject.DataModelPCORnet Data Model
local.subject.EvalTypeClinician Reviewed
local.subject.MedTermCharBrand Pack Name
local.subject.MedTermCharSemantic Branded Drug
local.subject.MedTermCharSemantic Clinical Drug
local.subject.MedTermCharSemantic Branded Drug Form
local.subject.MedTermCharSemantic Clinical Drug Form
local.subject.MedTermCharSemantic Branded Drug Component
local.subject.MedTermCharSemantic Clinical Drug Component
local.subject.flatIndependent Variable
local.subject.flatCohort Definition
local.subject.flatExclusion Criteria
relation.isStudyOfConceptSet6df51ca1-7a01-4551-b1f1-ca70aaf2c5ae
relation.isStudyOfConceptSet.latestForDiscovery6df51ca1-7a01-4551-b1f1-ca70aaf2c5ae

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
rx_2022_02_Deflazacort_V1.csv
Size:
7.3 KB
Format:
Comma-Separated Values
Download

Domains

Medication Concept Sets